Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

A Study of Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas

Study:

Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas

Rationale:

n/a

Purpose:

The purpose of this study is to evaluate the efficacy of ultraviolet-A (UVA)-induced cross-linking of corneal collagen (CXL) as a method to increase the biomechanical and biochemical stability of the cornea by inducing additional cross-links within or between collagen fibers using UVA light and the photo- mediator riboflavin.

Study Status: Recruiting

Recruiting:
n/a

Condition Intervention Phase
Keratoconus Device: Theralight crosslinking and Riboflavin Phase 4

Verified by Cxlusa October, 2013

Sponsored by: Cxlusa
Information provided by: Cxlusa
ClinicalTrials.gov identifier: NCT01956474

Study Type: Interventional

Study Design: Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

n/a n/a

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site